NCT00386971View on ClinicalTrials.gov

Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
HyperlipidemiaHIV Infections
Interventions
DIETARY_SUPPLEMENT

L-carnitine

3 grams daily in liquid form by mouth

OTHER

placebo

1 oz sweet tasting liquid daily by mouth

Trial Locations (1)

95817

GCRC UC Davis, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT00386971 - Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART | Biotech Hunter | Biotech Hunter